CN Patent

CN103200944B — 包含丁丙诺啡的经皮治疗系统

Assigned to Hexal AG · Expires 2016-05-04 · 10y expired

What this patent protects

本发明涉及包含丁丙诺啡的经皮治疗系统（TTS）和所述TTS的生产方法。经皮治疗系统用于丁丙诺啡及其类似物的经皮给药。具体而言，本发明涉及经皮治疗系统（TTS）用于止痛目的的用途。本发明的TTS包含含丁丙诺啡和粘合组分的经皮药物递送组合物，所述粘合组分是交联和非交联丙烯酸酯类聚合物以及包含酮酸的渗透促进剂的混合物。

USPTO Abstract

本发明涉及包含丁丙诺啡的经皮治疗系统（TTS）和所述TTS的生产方法。经皮治疗系统用于丁丙诺啡及其类似物的经皮给药。具体而言，本发明涉及经皮治疗系统（TTS）用于止痛目的的用途。本发明的TTS包含含丁丙诺啡和粘合组分的经皮药物递送组合物，所述粘合组分是交联和非交联丙烯酸酯类聚合物以及包含酮酸的渗透促进剂的混合物。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN103200944B
Jurisdiction: CN
Classification: —
Expires: 2016-05-04
Drug substance claim: No
Drug product claim: No
Assignee: Hexal AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.